CMV seropositivity is a potential novel risk factor for severe COVID-19 in non-geriatric patients
Simone Weber(Institute of Medical Microbiology and Hygiene), Dirk H. Busch(German Center for Infection Research), Johanna Erber(TUM Klinikum), Victoria Kehl(Technical University of Munich), K Wagner(Institute of Medical Microbiology and Hygiene), Philipp Schommers(University of Cologne), Markus Gerhard(German Center for Infection Research), Dieter Hoffmann(Technical University of Munich), Elvira D’Ippolito(Fondazione IRCCS Istituto Nazionale dei Tumori), Theresa Burrell(Institute of Medical Microbiology and Hygiene), Max Augustin(University of Cologne), Ana-Marija Jetzlsperger(Technical University of Munich), Claudia S. Crowell(German Center for Infection Research), Christof Winter(TUM Klinikum), Ulrike Protzer(German Center for Infection Research), Christoph D. Spinner(TUM Klinikum), Kilian Schober(Friedrich-Alexander-Universität Erlangen-Nürnberg)
Cited by 2
Related Papers
Guidelines for the use of flow cytometry and cell sorting in immunological studies (second edition)
|European Journal of Immunology|2019|1k
Direct identification of clinically relevant neoepitopes presented on native human melanoma tissue by mass spectrometry
|Nature Communications|2016|727